First human test of new drug for tough blood cancers halted early
NCT ID NCT05787496
Summary
This early-stage study tested a new drug called NC525 in adults with advanced blood cancers that had returned or stopped responding to standard treatments. The main goal was to check the drug's safety and side effects in 28 participants. The study was terminated early, and while it also looked for signs of effectiveness, its primary focus was on determining safe dosage levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
City of Hope
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
-
Weill Cornell Medicine
New York, New York, 10022, United States
Conditions
Explore the condition pages connected to this study.